4//SEC Filing
Degnan Chris 4
Accession 0001415889-24-024932
CIK 0001668243other
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 4:22 PM ET
Size
7.8 KB
Accession
0001415889-24-024932
Insider Transaction Report
Form 4
Degnan Chris
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2024-10-08+13,450→ 13,450 total→ Ordinary Shares (13,450 underlying) - Award
Employee Stock Option (right to buy)
2024-10-08+74,142→ 74,142 totalExercise: $13.11Exp: 2034-10-08→ Ordinary Shares (74,142 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]1/3 of the shares underlying the restricted stock units will vest on each of October 8, 2025, October 8, 2026 and October 8, 2027.
- [F3]1/3 of the shares underlying the stock option will vest on each of October 8, 2025, October 8, 2026 and October 8, 2027.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001741968
Filing Metadata
- Form type
- 4
- Filed
- Oct 8, 8:00 PM ET
- Accepted
- Oct 9, 4:22 PM ET
- Size
- 7.8 KB